Werfen at ISLH Congress 2024

Werfen made a significant impact at the ISLH Congress in May 2024,

showcasing its commitment to advancing patient care through innovative laboratory solutions. The event provided a platform for Werfen to connect with industry peers, share expertise, and highlight its latest advancements in laboratory diagnostics.

A Focus on Patient Care

Werfen's participation centered around the theme of powering patient care. The company demonstrated how its comprehensive portfolio of laboratory solutions can improve patient outcomes by enabling faster, more accurate, and efficient diagnostics.

Key Highlights

  • Innovative Product Showcase: Werfen was present during the poster session with a Poster with the topic of Evaluation of recovery of factor IX replacement therapy with HemosIL Chromogenic Factor IX: Link to ELC (PDF here Evaluation of recovery of factor IX replacement therapy with HemosIL Chromogenic Factor IX.pdf)
  • Expert Presentations: Over three days experts shared their knowledge through engaging presentations on the latest trends and challenges in laboratory medicine. Link to Congress report on ELC

Empowering Laboratories for the Future

Werfen's presence at the ISLH Congress is a testimony to our commitment to Powering Patient Care as a leader in laboratory diagnostics.

Last modified on Thursday, 12 September 2024 06:49

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top